GSK's linerixibat achieved significant itch reduction in a late-stage trial for cholestatic pruritus, meeting key goals. Read ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

While it may be helpful to take turmeric every day due to its anti-inflammatory benefits, it's possible to overdo it. Here's ...

Speaking in an emotional interview on Biola Bayo’s podcast, Harrison disclosed that he was forced to sell his house, cars, ...

About 200,000 people in Nigeria, mostly children, lose their lives annually from food-related diseases. In addition, Nigeria ...

European Region has the heaviest alcohol consumption of all regions in the world, causing a significant reduction in life expectancy, especially among men. Approximately 800,000 lives are lost each ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...

The findings, published in BMC Oral Health, suggest that incorporating routine oral health assessments into the management of ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK.

Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

Signs your nails reveal about liver health decline with early changes like pale beds, ripples, white bands, yellowing, and ...

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...